Literature DB >> 30683165

Cognition, social cognition, and Self-assessment in schizophrenia: prediction of different elements of everyday functional outcomes.

Juliet Silberstein1, Philip D Harvey1.   

Abstract

A growing body of research has shown that two domains of cognition, neurocognition and social cognition, predict different domains of real-world outcomes in people with schizophrenia. Social cognition has been shown to predict social outcomes but not non-social outcomes (e.g. living independently), and neurocognition provides minimal prediction of social outcomes (e.g. interpersonal relationships). The differing predictive value of neurocognition and social cognition has led to an exploration of potential factors that interact with cognition to influence everyday outcomes. Functional skills, negative symptoms, and self-assessment have shown particularly promising relationships with cognitive ability. Several consensus studies have pinpointed valid performance-based assessments. High-contact informant ratings have additionally been shown to be highly accurate. The emerging understanding of divergent patterns of predicting outcomes and reliable assessments present an opportunity to improve treatment targets and real-world outcomes for individuals with schizophrenia. In particular, a recently defined component of metacognition has shown particular promise. Introspective accuracy (IA) addresses how well individuals evaluate their own abilities. Emerging research has found that IA of neurocognitive ability better predicts everyday functional deficits than scores on performance-based measures of neurocognitive skills and has found that IA of social cognition accounts unique variance in real world disability above social cognitive abilities. Intriguingly, IA of neurocognition appears to preferentially predict non-social outcomes while IA of social cognition predicts social outcomes.

Entities:  

Keywords:  Cognition; Functional Outcome; Schizophrenia; Social Cognition; self-assessment

Mesh:

Year:  2019        PMID: 30683165      PMCID: PMC6414257          DOI: 10.1017/S1092852918001414

Source DB:  PubMed          Journal:  CNS Spectr        ISSN: 1092-8529            Impact factor:   3.790


  38 in total

Review 1.  The structure of negative symptoms within schizophrenia: implications for assessment.

Authors:  Jack J Blanchard; Alex S Cohen
Journal:  Schizophr Bull       Date:  2005-10-27       Impact factor: 9.306

2.  Evaluation of functionally meaningful measures for clinical trials of cognition enhancement in schizophrenia.

Authors:  Michael F Green; Nina R Schooler; Robert S Kern; Fred J Frese; Wendy Granberry; Philip D Harvey; Craig N Karson; Nancy Peters; Michelle Stewart; Larry J Seidman; John Sonnenberg; William S Stone; David Walling; Ellen Stover; Stephen R Marder
Journal:  Am J Psychiatry       Date:  2011-02-01       Impact factor: 18.112

3.  Prediction of real-world functional disability in chronic mental disorders: a comparison of schizophrenia and bipolar disorder.

Authors:  Christopher R Bowie; Colin Depp; John A McGrath; Paula Wolyniec; Brent T Mausbach; Mary H Thornquist; James Luke; Thomas L Patterson; Philip D Harvey; Ann E Pulver
Journal:  Am J Psychiatry       Date:  2010-05-17       Impact factor: 18.112

4.  Social Cognition Psychometric Evaluation: Results of the Initial Psychometric Study.

Authors:  Amy E Pinkham; David L Penn; Michael F Green; Philip D Harvey
Journal:  Schizophr Bull       Date:  2015-05-04       Impact factor: 9.306

5.  Validating the measurement of real-world functional outcomes: phase I results of the VALERO study.

Authors:  Philip D Harvey; Tenko Raykov; Elizabeth W Twamley; Lea Vella; Robert K Heaton; Thomas L Patterson
Journal:  Am J Psychiatry       Date:  2011-05-15       Impact factor: 18.112

6.  Clinical, functional, and intertask correlations of measures developed by the Cognitive Neuroscience Test Reliability and Clinical Applications for Schizophrenia Consortium.

Authors:  James M Gold; Deanna M Barch; Cameron S Carter; Steven Dakin; Steven J Luck; Angus W MacDonald; J Daniel Ragland; Charan Ranganath; Ilona Kovacs; Steven M Silverstein; Milton Strauss
Journal:  Schizophr Bull       Date:  2011-11-17       Impact factor: 9.306

7.  Assessing everyday functioning in schizophrenia: not all informants seem equally informative.

Authors:  Samir Sabbag; Elizabeth M Twamley; Lea Vella; Robert K Heaton; Thomas L Patterson; Philip D Harvey
Journal:  Schizophr Res       Date:  2011-05-26       Impact factor: 4.939

8.  Determinants of real-world functional performance in schizophrenia subjects: correlations with cognition, functional capacity, and symptoms.

Authors:  Christopher R Bowie; Abraham Reichenberg; Thomas L Patterson; Robert K Heaton; Philip D Harvey
Journal:  Am J Psychiatry       Date:  2006-03       Impact factor: 18.112

9.  The Schizophrenia Cognition Rating Scale: an interview-based assessment and its relationship to cognition, real-world functioning, and functional capacity.

Authors:  Richard S E Keefe; Margaret Poe; Trina M Walker; Joseph W Kang; Philip D Harvey
Journal:  Am J Psychiatry       Date:  2006-03       Impact factor: 18.112

Review 10.  Negative symptoms in schizophrenia: avolition and Occam's razor.

Authors:  George Foussias; Gary Remington
Journal:  Schizophr Bull       Date:  2008-07-21       Impact factor: 9.306

View more
  16 in total

Review 1.  Translation-Focused Approaches to GPCR Drug Discovery for Cognitive Impairments Associated with Schizophrenia.

Authors:  Cassandra J Hatzipantelis; Monica Langiu; Teresa H Vandekolk; Tracie L Pierce; Jess Nithianantharajah; Gregory D Stewart; Christopher J Langmead
Journal:  ACS Pharmacol Transl Sci       Date:  2020-10-28

2.  A Cross-Sectional Study on Associations Between BDNF, CRP, IL-6 and Clinical Symptoms, Cognitive and Personal Performance in Patients With Paranoid Schizophrenia.

Authors:  Egor Chumakov; Mariia Dorofeikova; Kristina Tsyrenova; Nataliia Petrova
Journal:  Front Psychiatry       Date:  2022-07-06       Impact factor: 5.435

3.  Brief battery of the Social Cognition Psychometric Evaluation study (BB-SCOPE): Development and validation in schizophrenia spectrum disorders.

Authors:  Tate F Halverson; Amy E Pinkham; Philip D Harvey; David L Penn
Journal:  J Psychiatr Res       Date:  2022-03-22       Impact factor: 5.250

4.  Depression predicts self assessment of social function in both patients with schizophrenia and healthy people.

Authors:  Lisa N Oliveri; Adam W Awerbuch; L Fredrik Jarskog; David L Penn; Amy Pinkham; Philip D Harvey
Journal:  Psychiatry Res       Date:  2019-11-06       Impact factor: 3.222

5.  Overconfidence in social cognitive decision making: Correlations with social cognitive and neurocognitive performance in participants with schizophrenia and healthy individuals.

Authors:  Michelle M Perez; Bianca A Tercero; David L Penn; Amy E Pinkham; Philip D Harvey
Journal:  Schizophr Res       Date:  2020-10-21       Impact factor: 4.939

6.  Anomaly detection to predict relapse risk in schizophrenia.

Authors:  Philip Henson; Ryan D'Mello; Aditya Vaidyam; Matcheri Keshavan; John Torous
Journal:  Transl Psychiatry       Date:  2021-01-11       Impact factor: 6.222

7.  Healthcare resource utilization and quality of life by cognitive impairment in patients with schizophrenia.

Authors:  Aditi Kadakia; Qi Fan; Jason Shepherd; Carole Dembek; Hollie Bailey; Chloe Walker; G Rhys Williams
Journal:  Schizophr Res Cogn       Date:  2021-12-21

8.  Daily Ecological Momentary Assessments of happy and sad moods in people with schizophrenia and bipolar disorders: What do participants who are never sad think about their activities and abilities?

Authors:  Sara E Jones; Raeanne C Moore; Colin A Depp; Robert A Ackerman; Amy E Pinkham; Philip D Harvey
Journal:  Schizophr Res Cogn       Date:  2021-06-16

9.  Effects of Psychotic Symptoms and Social Cognition on Job Retention in Patients with Schizophrenia in Korea.

Authors:  Mihwa Han; Seong Sook Jun
Journal:  Int J Environ Res Public Health       Date:  2020-04-11       Impact factor: 3.390

10.  Executive dysfunction in schizophrenia: Predictors of the discrepancy between subjective and objective measures.

Authors:  Ingvild Haugen; Jan Stubberud; Torill Ueland; Elisabeth Haug; Merete Glenne Øie
Journal:  Schizophr Res Cogn       Date:  2021-06-15
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.